$135M series C buys Vividion flexibility to explore broad pipeline
Crossover investors, deals with Roche, BMS provide runway
A new venture round back by deep-pocketed crossover investors and a pair of pharma deals give Vividion runway to explore a platform based on technology from Ben Cravatt’s lab.
Feb 25, 2021 | 3:23 AM GMT
After its $135 million series C raise Wednesday, Vividion has everything in